BIIB
NASDAQ · Biotechnology
Biogen Inc
$191.06
+1.88 (+0.99%)
Performance
1D
—
1W
—
1M
—
3M
+8.05%
6M
+37.93%
1Y
+36.15%
YTD
+7.45%
Open$189.00
Previous Close$189.18
Day High$192.28
Day Low$188.36
52W High$202.41
52W Low$110.04
Volume—
Avg Volume834.2K
Market Cap26.64B
P/E Ratio20.60
EPS$8.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$179.51
Above
SMA 200
$150.33
Above
RSI (14)
64.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
43 analysts
Price Target
-52.1% upside
Current
$191.06
$191.06
Target
$91.45
$91.45
$57.23
$91.45 avg
$114.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.87B | 9.96B | 3.09B |
| Net Income | 1.29B | 1.17B | 745.08M |
| Profit Margin | 13.1% | 12.4% | 24.1% |
| EBITDA | 2.54B | 2.44B | 1.15B |
| Free Cash Flow | — | — | 775.19M |
| Rev Growth | -0.9% | -0.9% | +20.7% |
| Debt/Equity | 0.34 | 0.34 | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $211.12 | +1.90% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.16 | -0.22% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $136.88 | -1.00% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $453.74 | -0.27% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $756.73 | +0.97% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.16% | 139.7 | 43.84B |